Evaluation of Retreatment of Failed Revasculatized Teeth by Revascularization
December 6, 2021 updated by: Mahmoud Ahmed Mahmoud, Minia University
Evaluation of Retreatment of Failed Revasculatized Teeth by Revascularization. Randomized Clinical Trial
Study will include 30 participants with failed revascularized young permenant teeth that will be retreated by revascularization and evaluated for success through 2 years
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 10 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- central and lateral immature incisors
- child from 8- 10 years old
- healthy chidren
- failed revascularization
Exclusion Criteria:
- medically compromised children
- mentally compromised children
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Revasularization
Revascularization of failed previously revascularized younge permenant inciors
|
Regain pulp vascularity for young permenant teeth
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Root completion
Time Frame: 2 years
|
Continue root maturation by radiographic assessment according to cvek classification ( increase root length)
|
2 years
|
|
Increase dentine thickness
Time Frame: 2 years
|
Increase dentine thickness as response to new formed pulp like tissues
|
2 years
|
|
Lesion healing
Time Frame: 2 years
|
Resolvation of periapical lesion through new bone formation, intact lamina dura, abscence of periapical radiolucency
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
December 1, 2021
Primary Completion (Anticipated)
December 1, 2023
Study Completion (Anticipated)
January 1, 2024
Study Registration Dates
First Submitted
October 28, 2021
First Submitted That Met QC Criteria
December 6, 2021
First Posted (Actual)
December 7, 2021
Study Record Updates
Last Update Posted (Actual)
December 7, 2021
Last Update Submitted That Met QC Criteria
December 6, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 801
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.